These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 26527150

  • 1. Structural insights into the interaction of human IgG1 with FcγRI: no direct role of glycans in binding.
    Oganesyan V, Mazor Y, Yang C, Cook KE, Woods RM, Ferguson A, Bowen MA, Martin T, Zhu J, Wu H, Dall'Acqua WF.
    Acta Crystallogr D Biol Crystallogr; 2015 Nov; 71(Pt 11):2354-61. PubMed ID: 26527150
    [Abstract] [Full Text] [Related]

  • 2. Structural mechanism of high affinity FcγRI recognition of immunoglobulin G.
    Lu J, Sun PD.
    Immunol Rev; 2015 Nov; 268(1):192-200. PubMed ID: 26497521
    [Abstract] [Full Text] [Related]

  • 3. Structure of FcγRI in complex with Fc reveals the importance of glycan recognition for high-affinity IgG binding.
    Lu J, Chu J, Zou Z, Hamacher NB, Rixon MW, Sun PD.
    Proc Natl Acad Sci U S A; 2015 Jan 20; 112(3):833-8. PubMed ID: 25561553
    [Abstract] [Full Text] [Related]

  • 4. Crystal structure of Fcγ receptor I and its implication in high affinity γ-immunoglobulin binding.
    Lu J, Ellsworth JL, Hamacher N, Oak SW, Sun PD.
    J Biol Chem; 2011 Nov 25; 286(47):40608-13. PubMed ID: 21965667
    [Abstract] [Full Text] [Related]

  • 5. Structural basis for binding of human IgG1 to its high-affinity human receptor FcγRI.
    Kiyoshi M, Caaveiro JM, Kawai T, Tashiro S, Ide T, Asaoka Y, Hatayama K, Tsumoto K.
    Nat Commun; 2015 Apr 30; 6():6866. PubMed ID: 25925696
    [Abstract] [Full Text] [Related]

  • 6. CD16a with oligomannose-type N-glycans is the only "low-affinity" Fc γ receptor that binds the IgG crystallizable fragment with high affinity in vitro.
    Subedi GP, Barb AW.
    J Biol Chem; 2018 Oct 26; 293(43):16842-16850. PubMed ID: 30213862
    [Abstract] [Full Text] [Related]

  • 7. A Method to Detect the Binding of Hyper-Glycosylated Fragment Crystallizable (Fc) Region of Human IgG1 to Glycan Receptors.
    Blundell P, Pleass R.
    Methods Mol Biol; 2019 Oct 26; 1904():417-421. PubMed ID: 30539483
    [Abstract] [Full Text] [Related]

  • 8. The high-affinity receptor for IgG, FcγRI, of humans and non-human primates.
    Chenoweth AM, Trist HM, Tan PS, Wines BD, Hogarth PM.
    Immunol Rev; 2015 Nov 26; 268(1):175-91. PubMed ID: 26497520
    [Abstract] [Full Text] [Related]

  • 9. High affinity IgG binding by FcgammaRI (CD64) is modulated by two distinct IgSF domains and the transmembrane domain of the receptor.
    Harrison PT, Allen JM.
    Protein Eng; 1998 Mar 26; 11(3):225-32. PubMed ID: 9613847
    [Abstract] [Full Text] [Related]

  • 10. The many faces of FcγRI: implications for therapeutic antibody function.
    Swisher JF, Feldman GM.
    Immunol Rev; 2015 Nov 26; 268(1):160-74. PubMed ID: 26497519
    [Abstract] [Full Text] [Related]

  • 11. The immunoglobulin G1 N-glycan composition affects binding to each low affinity Fc γ receptor.
    Subedi GP, Barb AW.
    MAbs; 2016 Nov 26; 8(8):1512-1524. PubMed ID: 27492264
    [Abstract] [Full Text] [Related]

  • 12. Conformational effects of N-glycan core fucosylation of immunoglobulin G Fc region on its interaction with Fcγ receptor IIIa.
    Sakae Y, Satoh T, Yagi H, Yanaka S, Yamaguchi T, Isoda Y, Iida S, Okamoto Y, Kato K.
    Sci Rep; 2017 Oct 23; 7(1):13780. PubMed ID: 29062024
    [Abstract] [Full Text] [Related]

  • 13. The 3.2-A crystal structure of the human IgG1 Fc fragment-Fc gammaRIII complex.
    Sondermann P, Huber R, Oosthuizen V, Jacob U.
    Nature; 2000 Jul 20; 406(6793):267-73. PubMed ID: 10917521
    [Abstract] [Full Text] [Related]

  • 14. The second and third extracellular domains of FcgammaRI (CD64) confer the unique high affinity binding of IgG2a.
    Hulett MD, Hogarth PM.
    Mol Immunol; 1998 Oct 20; 35(14-15):989-96. PubMed ID: 9881694
    [Abstract] [Full Text] [Related]

  • 15. Structural characterization of a mutated, ADCC-enhanced human Fc fragment.
    Oganesyan V, Damschroder MM, Leach W, Wu H, Dall'Acqua WF.
    Mol Immunol; 2008 Apr 20; 45(7):1872-82. PubMed ID: 18078997
    [Abstract] [Full Text] [Related]

  • 16. Structural analysis of Fc/FcγR complexes: a blueprint for antibody design.
    Caaveiro JM, Kiyoshi M, Tsumoto K.
    Immunol Rev; 2015 Nov 20; 268(1):201-21. PubMed ID: 26497522
    [Abstract] [Full Text] [Related]

  • 17. Restricted motion of the conserved immunoglobulin G1 N-glycan is essential for efficient FcγRIIIa binding.
    Subedi GP, Hanson QM, Barb AW.
    Structure; 2014 Oct 07; 22(10):1478-88. PubMed ID: 25199692
    [Abstract] [Full Text] [Related]

  • 18. Restricted processing of CD16a/Fc γ receptor IIIa N-glycans from primary human NK cells impacts structure and function.
    Patel KR, Roberts JT, Subedi GP, Barb AW.
    J Biol Chem; 2018 Mar 09; 293(10):3477-3489. PubMed ID: 29330305
    [Abstract] [Full Text] [Related]

  • 19. In vitro glycoengineering of IgG1 and its effect on Fc receptor binding and ADCC activity.
    Thomann M, Schlothauer T, Dashivets T, Malik S, Avenal C, Bulau P, Rüger P, Reusch D.
    PLoS One; 2015 Mar 09; 10(8):e0134949. PubMed ID: 26266936
    [Abstract] [Full Text] [Related]

  • 20. FcγRI FG-loop functions as a pH sensitive switch for IgG binding and release.
    Lu J, Spencer M, Zou Z, Traver M, Brzostowski J, Sun PD.
    Front Immunol; 2023 Mar 09; 14():1100499. PubMed ID: 36814926
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.